The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUPP.L Regulatory News (SUPP)

  • There is currently no data for SUPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Silicon Valley Bank

15 Mar 2023 07:00

RNS Number : 9642S
Schroder UK Public Private Tst plc
15 March 2023
 

Schroder UK Public Private Trust plc

 

Update on Silicon Valley Bank

 

 

Schroder UK Public Private Trust plc (the "Company") provides this update following recent developments related to Silicon Valley Bank ("SVB").

 

Latest developments

 

Following the closure of SVB by the California Department of Financial Protection and Innovation on Friday 10 March 2023, the Company welcomes the statement2 on Monday 13 March 2023 from The Federal Deposit Insurance Corporation ("FDIC") confirming the transfer of all deposits and substantially all assets of the former Silicon Valley Bank of Santa Clara, California, to a newly created, full-service FDIC-operated 'bridge bank' in an action designed to protect all depositors. As such, SVB depositors will have full access to their money beginning the morning of 13 March 2023, when Silicon Valley Bank, N.A., the bridge bank, opens and resumes normal banking hours and activities.

 

The Company further welcomes the statement1 on Monday 13 March 2023 from the Bank of England ("BoE") that it has taken the decision to sell Silicon Valley Bank UK Limited ("SVBUK"), the UK subsidiary of the US bank, to HSBC UK Bank Plc. This action has been taken to stabilise SVBUK, ensuring the continuity of banking services, minimising disruption to the UK technology sector and supporting confidence in the financial system. The BoE and HM Treasury confirmed that all depositors' money with SVBUK is safe and secure as a result of this transaction. SVBUK's business will continue to be operated normally by SVBUK. All services will continue to operate as normal and customers should not notice any changes.

 

Exposure

 

In the spirit of full transparency, we would like to update you on the Company's direct and indirect exposure to SVB.

 

· Schroder UK Public Private Trust plc (the "Company") has no direct banking relationship with SVB.

· The Company's underlying portfolio companies have a range of banking relationships which in some instances include SVB and SVBUK. While the review of the portfolio is ongoing, on the basis of the information the Manager has available, the Company's estimated indirect exposure across its portfolio is ~0.8% of Net Asset Value3.

 

· Schroders Capital Management (Switzerland) AG as delegated Portfolio Manager of the Company and its funds have no direct banking relationship with SVB. Therefore there is no direct exposure from their funds or mandates.

 

Enquiries:

Schroder Investment Management Limited

Augustine Chipungu (Press) 0207 658 2106

Shilla Pindoria (Company Secretary) 0207 658 7267

John Spedding 0207 658 3206

 

 

1 https://www.bankofengland.co.uk/news/2023/march/statement-on-silicon-valley-bank

 

2 https://www.fdic.gov/news/press-releases/2023/pr23019.html

 

3 Calculated based on the total amount understood by us to be deposited by portfolio companies with SVB and SVBUK, in each case multiplied by the Company's fully diluted ownership percentage of the relevant portfolio company, and the unaudited daily net asset value as of 10 March 2023 (£255.4 million).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKDLFLKDEFA
Date   Source Headline
9th Dec 202210:34 amRNSNet Asset Value(s)
8th Dec 202210:54 amRNSNet Asset Value(s)
7th Dec 20224:47 pmRNSTransaction in Own Shares
7th Dec 202210:51 amRNSNet Asset Value(s)
6th Dec 202210:47 amRNSNet Asset Value(s)
5th Dec 202210:40 amRNSNet Asset Value(s)
2nd Dec 202210:46 amRNSNet Asset Value(s)
1st Dec 202211:51 amRNSNet Asset Value(s)
30th Nov 20225:24 pmRNSTotal Voting Rights
30th Nov 202210:39 amRNSNet Asset Value(s)
29th Nov 20225:10 pmRNSTransaction in Own Shares
29th Nov 202210:52 amRNSNet Asset Value(s)
28th Nov 202210:56 amRNSNet Asset Value(s)
25th Nov 202210:58 amRNSNet Asset Value(s)
24th Nov 202211:49 amRNSNet Asset Value(s)
23rd Nov 20224:56 pmRNSTransaction in Own Shares
23rd Nov 202210:39 amRNSNet Asset Value(s)
22nd Nov 202211:30 amRNSNet Asset Value(s)
21st Nov 202211:17 amRNSNet Asset Value(s)
18th Nov 202211:24 amRNSNet Asset Value(s)
17th Nov 20224:55 pmRNSTransaction in Own Shares
17th Nov 202211:13 amRNSNet Asset Value(s)
17th Nov 20227:00 amRNSInvestment in A2 Biotherapeutics
16th Nov 202211:01 amRNSNet Asset Value(s)
15th Nov 202211:23 amRNSNet Asset Value(s)
14th Nov 202211:32 amRNSNet Asset Value(s)
11th Nov 202211:32 amRNSNet Asset Value(s)
10th Nov 202211:35 amRNSNet Asset Value(s)
9th Nov 20224:40 pmRNSSecond Price Monitoring Extn
9th Nov 20224:35 pmRNSPrice Monitoring Extension
9th Nov 202211:46 amRNSNet Asset Value(s)
8th Nov 202211:41 amRNSNet Asset Value(s)
7th Nov 20224:54 pmRNSTransaction in Own Shares
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Nov 202211:51 amRNSNet Asset Value(s)
4th Nov 20225:58 pmRNSTransaction in Own Shares
4th Nov 20224:41 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 202211:53 amRNSNet Asset Value(s)
4th Nov 20227:00 amRNSInvestment in iOnctura
3rd Nov 20225:09 pmRNSTransaction in Own Shares
3rd Nov 202211:23 amRNSNet Asset Value(s)
2nd Nov 20225:43 pmRNSTransaction in Own Shares
2nd Nov 202211:06 amRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
1st Nov 202211:16 amRNSNet Asset Value(s)
31st Oct 20225:30 pmRNSTotal Voting Rights
31st Oct 20225:17 pmRNSTransaction in Own Shares
31st Oct 202211:31 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.